1
|
Grigorov I, Pejić S, Todorović A, Drakulić D, Veljković F, Vukajlović JM, Bobić K, Soldatović I, Đurašević S, Jasnić N, Stanković S, Glumac S, Mihailović-Vučinić V, Milenković B. Serum High-Mobility Group Box 1 and Heme Oxygenase-1 as Biomarkers in COVID-19 Patients at Hospital Admission. Int J Mol Sci 2023; 24:13164. [PMID: 37685970 PMCID: PMC10488018 DOI: 10.3390/ijms241713164] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2023] [Revised: 08/06/2023] [Accepted: 08/18/2023] [Indexed: 09/10/2023] Open
Abstract
The careful monitoring of patients with mild/moderate COVID-19 is of particular importance because of the rapid progression of complications associated with COVID-19. For prognostic reasons and for the economic management of health care resources, additional biomarkers need to be identified, and their monitoring can conceivably be performed in the early stages of the disease. In this retrospective cross-sectional study, we found that serum concentrations of high-mobility group box 1 (HMGB1) and heme oxygenase-1 (HO-1), at the time of hospital admission, could be useful biomarkers for COVID-19 management. The study included 160 randomly selected recovered patients with mild to moderate COVID-19 on admission. Compared with healthy controls, serum HMGB1 and HO-1 levels increased by 487.6 pg/mL versus 43.1 pg/mL and 1497.7 pg/mL versus 756.1 pg/mL, respectively. Serum HO-1 correlated significantly with serum HMGB1, oxidative stress parameters (malondialdehyde (MDA), the phosphatidylcholine/lysophosphatidylcholine ratio (PC/LPC), the ratio of reduced and oxidative glutathione (GSH/GSSG)), and anti-inflammatory acute phase proteins (ferritin, haptoglobin). Increased heme catabolism/hemolysis were not detected. We hypothesize that the increase in HO-1 in the early phase of COVID-19 disease is likely to have a survival benefit by providing protection against oxidative stress and inflammation, whereas the level of HMGB1 increase reflects the activity of the innate immune system and represents levels within which the disease can be kept under control.
Collapse
Affiliation(s)
- Ilijana Grigorov
- Institute for Biological Research “Siniša Stanković”—National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia
| | - Snežana Pejić
- Vinča Institute of Nuclear Sciences—National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia; (S.P.); (A.T.); (D.D.); (F.V.); (J.M.V.); (K.B.)
| | - Ana Todorović
- Vinča Institute of Nuclear Sciences—National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia; (S.P.); (A.T.); (D.D.); (F.V.); (J.M.V.); (K.B.)
| | - Dunja Drakulić
- Vinča Institute of Nuclear Sciences—National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia; (S.P.); (A.T.); (D.D.); (F.V.); (J.M.V.); (K.B.)
| | - Filip Veljković
- Vinča Institute of Nuclear Sciences—National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia; (S.P.); (A.T.); (D.D.); (F.V.); (J.M.V.); (K.B.)
| | - Jadranka Miletić Vukajlović
- Vinča Institute of Nuclear Sciences—National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia; (S.P.); (A.T.); (D.D.); (F.V.); (J.M.V.); (K.B.)
| | - Katarina Bobić
- Vinča Institute of Nuclear Sciences—National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia; (S.P.); (A.T.); (D.D.); (F.V.); (J.M.V.); (K.B.)
| | - Ivan Soldatović
- Institute of Medical Statistics and Informatic, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia;
| | - Siniša Đurašević
- Faculty of Biology, University of Belgrade, 11000 Belgrade, Serbia; (S.Đ.); (N.J.)
| | - Nebojša Jasnić
- Faculty of Biology, University of Belgrade, 11000 Belgrade, Serbia; (S.Đ.); (N.J.)
| | - Sanja Stanković
- Center for Medical Biochemistry, University Clinical Center of Serbia, 11000 Belgrade, Serbia;
| | - Sofija Glumac
- Institute of Pathology, School of Medicine, University of Belgrade, 11000 Belgrade, Serbia; (S.G.); (V.M.-V.); (B.M.)
| | - Violeta Mihailović-Vučinić
- Institute of Pathology, School of Medicine, University of Belgrade, 11000 Belgrade, Serbia; (S.G.); (V.M.-V.); (B.M.)
- Clinic for Pulmonary Diseases, University Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia
| | - Branislava Milenković
- Institute of Pathology, School of Medicine, University of Belgrade, 11000 Belgrade, Serbia; (S.G.); (V.M.-V.); (B.M.)
- Clinic for Pulmonary Diseases, University Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia
| |
Collapse
|
2
|
Freitag-Wolf S, Schupp JC, Frye BC, Fischer A, Anwar R, Kieszko R, Mihailović-Vučinić V, Milanowski J, Jovanovic D, Zissel G, Bargagli E, Rottoli P, Bumbacea D, Jonkers R, Ho LP, Gaede KI, Dubaniewicz A, Marshall BG, Günther A, Petrek M, Keane MP, Haraldsdottir SO, Bonella F, Grah C, Peroš-Golubičić T, Kadija Z, Pabst S, Grohé C, Strausz J, Safrankova M, Millar A, Homolka J, Wuyts WA, Spencer LG, Pfeifer M, Valeyre D, Poletti V, Wirtz H, Prasse A, Schreiber S, Dempfle A, Müller-Quernheim J. Genetic and geographic influence on phenotypic variation in European sarcoidosis patients. Front Med (Lausanne) 2023; 10:1218106. [PMID: 37621457 PMCID: PMC10446882 DOI: 10.3389/fmed.2023.1218106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2023] [Accepted: 07/25/2023] [Indexed: 08/26/2023] Open
Abstract
Introduction Sarcoidosis is a highly variable disease in terms of organ involvement, type of onset and course. Associations of genetic polymorphisms with sarcoidosis phenotypes have been observed and suggest genetic signatures. Methods After obtaining a positive vote of the competent ethics committee we genotyped 1909 patients of the deeply phenotyped Genetic-Phenotype Relationship in Sarcoidosis (GenPhenReSa) cohort of 31 European centers in 12 countries with 116 potentially disease-relevant single-nucleotide polymorphisms (SNPs). Using a meta-analysis, we investigated the association of relevant phenotypes (acute vs. sub-acute onset, phenotypes of organ involvement, specific organ involvements, and specific symptoms) with genetic markers. Subgroups were built on the basis of geographical, clinical and hospital provision considerations. Results In the meta-analysis of the full cohort, there was no significant genetic association with any considered phenotype after correcting for multiple testing. In the largest sub-cohort (Serbia), we confirmed the known association of acute onset with TNF and reported a new association of acute onset an HLA polymorphism. Multi-locus models with sets of three SNPs in different genes showed strong associations with the acute onset phenotype in Serbia and Lublin (Poland) demonstrating potential region-specific genetic links with clinical features, including recently described phenotypes of organ involvement. Discussion The observed associations between genetic variants and sarcoidosis phenotypes in subgroups suggest that gene-environment-interactions may influence the clinical phenotype. In addition, we show that two different sets of genetic variants are permissive for the same phenotype of acute disease only in two geographic subcohorts pointing to interactions of genetic signatures with different local environmental factors. Our results represent an important step towards understanding the genetic architecture of sarcoidosis.
Collapse
Affiliation(s)
- Sandra Freitag-Wolf
- Institute of Medical Informatics and Statistics, Kiel University, Kiel, Germany
| | - Jonas C. Schupp
- Department of Pneumology, Faculty of Medicine, University Medical Centre, Freiburg, Germany
- Department of Respiratory Medicine, Hannover Medical School, German Center for Lung Research (DZL), Hannover, Germany
- Biomedical Research in End-Stage and Obstructive Lung Disease (BREATH), Hannover Medical School (MHH), German Center for Lung Research (DZL), Hannover, Germany
| | - Björn C. Frye
- Department of Pneumology, Faculty of Medicine, University Medical Centre, Freiburg, Germany
| | - Annegret Fischer
- Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany
| | - Raihanatul Anwar
- Institute of Medical Informatics and Statistics, Kiel University, Kiel, Germany
| | - Robert Kieszko
- Department of Pneumonology, Oncology and Allergology, Medical University of Lublin, Lublin, Poland
| | | | - Janusz Milanowski
- Department of Pneumonology, Oncology and Allergology, Medical University of Lublin, Lublin, Poland
| | | | - Gernot Zissel
- Department of Pneumology, Faculty of Medicine, University Medical Centre, Freiburg, Germany
| | - Elena Bargagli
- Respiratory Diseases and Lung Transplant Unit, University Hospital, Siena, Italy
| | - Paola Rottoli
- Respiratory Diseases and Lung Transplant Unit, University Hospital, Siena, Italy
| | - Dragos Bumbacea
- Department of Cardio-Thoracic Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
| | - René Jonkers
- Pulmonology Department, Academic Medical Center Amsterdam, Amsterdam, Netherlands
| | - Ling-Pei Ho
- Oxford Sarcoidosis Service, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, United Kingdom
| | | | - Anna Dubaniewicz
- Department of Pulmonology, Medical University of Gdansk, Gdansk, Poland
| | - Ben G. Marshall
- Department of Respiratory Medicine, University Hospital, Southampton, United Kingdom
| | - Andreas Günther
- Department of Pneumology and Intensive Care, University Hospital, Giessen, Germany
| | - Martin Petrek
- Faculty of Medicine and Dentistry, Palacký University and University Hospital Olomouc, Olomouc, Czechia
| | - Michael P. Keane
- Division of Pulmonary and Critical Care Medicine, University College Dublin and St Vincent’s University Hospital, Dublin, Ireland
| | | | - Francesco Bonella
- Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen, Universitätsklinik Essen, Essen, Germany
| | | | | | - Zamir Kadija
- Foundation IRCCS Policlinico San Matteo - Pulmonology Unit, Pavia, Italy
| | - Stefan Pabst
- Department of Pneumology, University Hospital, Bonn, Germany
| | | | | | - Martina Safrankova
- Thomayer Hospital and 1st Faculty of Medicine, Charles University, Praha, Czechia
| | - Ann Millar
- Pulmonary Department, University Hospital, Bristol, United Kingdom
| | - Jiří Homolka
- Prague General Hospital, Charles University, Prague, Czechia
| | - Wim A. Wuyts
- Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), University Hospital, Leuven, Belgium
| | - Lisa G. Spencer
- Liverpool Interstitial Lung Disease Service, Aintree Chest Centre, Liverpool University Hospitals NHS FT, Liverpool, United Kingdom
| | - Michael Pfeifer
- Department of Pneumology, University Hospital Regensburg, Regensburg, Germany
| | - Dominique Valeyre
- Groupe Hospitalier Avicenne-Jean Verdier-René Muret, Service de Pneumologie, Bobigny, France
| | - Venerino Poletti
- Pulmonary Unit, Department of Thoracic Diseases, Azienda USL Romagna, GB Morgagni-L-Pierantoni Hospital, Forlì, Italy
| | - Hubertus Wirtz
- Department of Pneumology, University Hospital Leipzig, Leipzig, Germany
| | - Antje Prasse
- Department of Pneumology, Faculty of Medicine, University Medical Centre, Freiburg, Germany
- Department of Respiratory Medicine, Hannover Medical School, German Center for Lung Research (DZL), Hannover, Germany
| | - Stefan Schreiber
- Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany
- Department of Internal Medicine I, University Hospital Schleswig-Holstein, Kiel, Germany
| | - Astrid Dempfle
- Institute of Medical Informatics and Statistics, Kiel University, Kiel, Germany
| | | |
Collapse
|
3
|
Stjepanović M, Škodrić-Trifunović V, Radisavljević-Pavlović S, Roksandić-Milenković M, Milin-Lazović J, Babić U, Mašković J, Buha I, Stojković-Lalošević M, Stojković M, Mihailović-Vučinić V. Patient, Healthcare System and Total Delay in Tuberculosis Diagnosis and Treatment Among Serbian Population. Acta Clin Croat 2018; 57:257-263. [PMID: 30431718 PMCID: PMC6532000 DOI: 10.20471/acc.2018.57.02.05] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
Abstract
SUMMARY – Currently, topical are studies that examine different reasons for delay of tuberculosis (TB) diagnosis and its impact on disease prognosis. The aim was to examine three time periods associated with treatment delay: patient related, health system related and total delay. This retrospective-prospective study included 100 consecutive patients hospitalized at Department of Pulmonology, Clinical Center of Serbia, in the period from March to December 2015. Study results showed median patient delay to be 92.5 days. Total delay was affected by patient related delay. Median healthcare delay was 18.5 days. Patients that reported excessive alcohol consumption were more likely to have prolonged time to seek medical help. Years of alcohol consumption yielded moderate positive correlation with patient related delay (r=0.362, p<0.001). Correlation between the number of cigarettes and patient delay was moderate, positive and statistically significant (r=0.314, p=0.001). Delay in seeking medical help was more likely in patients with negative family history of TB. There was no difference in the effect of the presence of symptoms on patient related delay (p>0.05). Clinical characteristics such as patient TB category and chest radiograph abnormalities were not associated with prolonged patient related delay (p>0.05). Study results point to the importance of health education and/or health intervention in the population group at a high risk of TB.
Collapse
Affiliation(s)
| | - Vesna Škodrić-Trifunović
- Department of Pulmonology, Clinical Center of Serbia, Belgrade, Serbia.,Faculty of Medicine, University of Belgrade, Belgrade, Serbia
| | | | - Marina Roksandić-Milenković
- Department of Pulmonology, Clinical Center of Serbia, Belgrade, Serbia.,Faculty of Medicine, University of Belgrade, Belgrade, Serbia
| | | | - Uroš Babić
- Faculty of Medicine, University of Belgrade, Belgrade, Serbia.,Clinical Center of Serbia, Department of Urology, Belgrade, Serbia
| | - Jovana Mašković
- Department of Pulmonology, Clinical Center of Serbia, Belgrade, Serbia
| | - Ivana Buha
- Department of Pulmonology, Clinical Center of Serbia, Belgrade, Serbia
| | | | - Mirjana Stojković
- Faculty of Medicine, University of Belgrade, Belgrade, Serbia.,Clinical Center of Serbia, Department of Gastroenterology and Hepatology, Belgrade, Serbia
| | - Violeta Mihailović-Vučinić
- Department of Pulmonology, Clinical Center of Serbia, Belgrade, Serbia.,Faculty of Medicine, University of Belgrade, Belgrade, Serbia
| |
Collapse
|
4
|
Schupp JC, Freitag-Wolf S, Bargagli E, Mihailović-Vučinić V, Rottoli P, Grubanovic A, Müller A, Jochens A, Tittmann L, Schnerch J, Olivieri C, Fischer A, Jovanovic D, Filipovic S, Videnovic-Ivanovic J, Bresser P, Jonkers R, O'Reilly K, Ho LP, Gaede KI, Zabel P, Dubaniewicz A, Marshall B, Kieszko R, Milanowski J, Günther A, Weihrich A, Petrek M, Kolek V, Keane MP, O'Beirne S, Donnelly S, Haraldsdottir SO, Jorundsdottir KB, Costabel U, Bonella F, Wallaert B, Grah C, Peroš-Golubičić T, Luisetti M, Kadija Z, Pabst S, Grohé C, Strausz J, Vašáková M, Sterclova M, Millar A, Homolka J, Slováková A, Kendrick Y, Crawshaw A, Wuyts W, Spencer L, Pfeifer M, Valeyre D, Poletti V, Wirtz H, Prasse A, Schreiber S, Krawczak M, Müller-Quernheim J. Phenotypes of organ involvement in sarcoidosis. Eur Respir J 2018; 51:51/1/1700991. [PMID: 29371378 DOI: 10.1183/13993003.00991-2017] [Citation(s) in RCA: 115] [Impact Index Per Article: 19.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2017] [Accepted: 10/25/2017] [Indexed: 01/08/2023]
Abstract
Sarcoidosis is a highly variable, systemic granulomatous disease of hitherto unknown aetiology. The GenPhenReSa (Genotype-Phenotype Relationship in Sarcoidosis) project represents a European multicentre study to investigate the influence of genotype on disease phenotypes in sarcoidosis.The baseline phenotype module of GenPhenReSa comprised 2163 Caucasian patients with sarcoidosis who were phenotyped at 31 study centres according to a standardised protocol.From this module, we found that patients with acute onset were mainly female, young and of Scadding type I or II. Female patients showed a significantly higher frequency of eye and skin involvement, and complained more of fatigue. Based on multidimensional correspondence analysis and subsequent cluster analysis, patients could be clearly stratified into five distinct, yet undescribed, subgroups according to predominant organ involvement: 1) abdominal organ involvement, 2) ocular-cardiac-cutaneous-central nervous system disease involvement, 3) musculoskeletal-cutaneous involvement, 4) pulmonary and intrathoracic lymph node involvement, and 5) extrapulmonary involvement.These five new clinical phenotypes will be useful to recruit homogenous cohorts in future biomedical studies.
Collapse
Affiliation(s)
| | - Sandra Freitag-Wolf
- Institute of Medical Informatics and Statistics, Christian-Albrechts-Universität, Kiel, Germany
| | - Elena Bargagli
- Respiratory Diseases and Lung Transplant Unit, AOUS - Medical and Surgical Sciences and Neuroscience Dept, Siena University, Siena, Italy
| | | | - Paola Rottoli
- Respiratory Diseases and Lung Transplant Unit, AOUS - Medical and Surgical Sciences and Neuroscience Dept, Siena University, Siena, Italy
| | - Aleksandar Grubanovic
- Dept of Pneumology, University Medical Centre, Faculty of Medicine, Freiburg, Germany
| | - Annegret Müller
- Dept of Pneumology, University Medical Centre, Faculty of Medicine, Freiburg, Germany.,Dept of Cardiology, Pneumology, Angiology and Intensive Care Medicine, University Hospital, Aachen, Germany
| | - Arne Jochens
- Institute of Medical Informatics and Statistics, Christian-Albrechts-Universität, Kiel, Germany
| | - Lukas Tittmann
- Popgen Biobank and Institute of Epidemiology, Christian-Albrechts-Universität, Kiel, Germany
| | - Jasmin Schnerch
- Dept of Pneumology, University Medical Centre, Faculty of Medicine, Freiburg, Germany.,Dept of Haematology and Oncology, University Medical Centre, Freiburg, Germany
| | - Carmela Olivieri
- Respiratory Diseases and Lung Transplant Unit, AOUS - Medical and Surgical Sciences and Neuroscience Dept, Siena University, Siena, Italy
| | - Annegret Fischer
- Institute of Clinical Molecular Biology, Christian-Albrechts-Universität, Kiel, Germany
| | - Dragana Jovanovic
- University Hospital of Lung Diseases, Clinical Centre of Serbia, Belgrade, Serbia
| | - Snežana Filipovic
- University Hospital of Lung Diseases, Clinical Centre of Serbia, Belgrade, Serbia
| | | | - Paul Bresser
- Pulmonology Dept, Academic Medical Center Amsterdam, Amsterdam, The Netherlands
| | - René Jonkers
- Pulmonology Dept, Academic Medical Center Amsterdam, Amsterdam, The Netherlands
| | | | - Ling-Pei Ho
- Oxford Sarcoidosis Service, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
| | - Karoline I Gaede
- Medical Hospital, Research Center Borstel, Borstel, Germany.,Leibniz Center for Medicine and Biosciences, Airway Research Center North, Member of the German Center for Lung Research, Borstel, Germany
| | - Peter Zabel
- Medical Hospital, Research Center Borstel, Borstel, Germany.,Leibniz Center for Medicine and Biosciences, Airway Research Center North, Member of the German Center for Lung Research, Borstel, Germany
| | - Anna Dubaniewicz
- Dept of Pulmonology, Medical University of Gdansk, Gdansk, Poland
| | | | - Robert Kieszko
- Dept of Pneumonology, Oncology and Allergology, Medical University of Lublin, Lublin, Poland
| | - Janusz Milanowski
- Dept of Pneumonology, Oncology and Allergology, Medical University of Lublin, Lublin, Poland
| | | | | | - Martin Petrek
- Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic.,University Hospital Olomouc, Olomouc, Czech Republic
| | - Vitezslav Kolek
- Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic.,University Hospital Olomouc, Olomouc, Czech Republic
| | - Michael P Keane
- University College Dublin, Dublin, Ireland.,St Vincent's University Hospital, Dublin, Ireland
| | - Sarah O'Beirne
- University College Dublin, Dublin, Ireland.,St Vincent's University Hospital, Dublin, Ireland
| | - Seamas Donnelly
- University College Dublin, Dublin, Ireland.,St Vincent's University Hospital, Dublin, Ireland
| | | | | | - Ulrich Costabel
- Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmbH, Universitätsklinik Essen, Essen, Germany
| | - Francesco Bonella
- Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmbH, Universitätsklinik Essen, Essen, Germany
| | | | | | | | - Mauritio Luisetti
- Pulmonology Unit, Foundation IRCCS Policlinico San Matteo, Pavia, Italy
| | - Zamir Kadija
- Pulmonology Unit, Foundation IRCCS Policlinico San Matteo, Pavia, Italy
| | | | | | | | - Martina Vašáková
- Thomayer Hospital, Prague, Czech Republic.,First Faculty of Medicine, Charles University, Prague, Czech Republic
| | - Martina Sterclova
- Thomayer Hospital, Prague, Czech Republic.,First Faculty of Medicine, Charles University, Prague, Czech Republic
| | | | - Jiří Homolka
- Prague General Hospital, Charles University, Prague, Czech Republic
| | - Alena Slováková
- Prague General Hospital, Charles University, Prague, Czech Republic
| | - Yvonne Kendrick
- Oxford Sarcoidosis Service, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
| | - Anjali Crawshaw
- Oxford Sarcoidosis Service, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
| | - Wim Wuyts
- University Hospital, Leuven, Belgium
| | | | | | - Dominique Valeyre
- Service de Pneumologie, Groupe Hospitalier Avicenne-Jean Verdier-René Muret, Bobigny, France
| | - Venerino Poletti
- Pulmonary Unit, Dept of Thoracic Diseases, Azienda USL Romagna, G.B. Morgagni-L. Pierantoni Hospital, Forlì, Italy
| | - Hubertus Wirtz
- Dept of Pneumology, University Hospital, Leipzig, Germany
| | - Antje Prasse
- Dept of Pneumology, University Medical Centre, Faculty of Medicine, Freiburg, Germany.,Dept of Pneumology, Hannover Medical School, Hannover, Germany
| | - Stefan Schreiber
- Institute of Clinical Molecular Biology, Christian-Albrechts-Universität, Kiel, Germany.,Dept of Internal Medicine, Christian-Albrechts-Universität, Kiel, Germany
| | - Michael Krawczak
- Institute of Medical Informatics and Statistics, Christian-Albrechts-Universität, Kiel, Germany
| | | |
Collapse
|
5
|
Mihailović-Vučinić V, Gvozdenović B, Stjepanović M, Vuković M, Marković-Denić L, Milovanović A, Videnović-Ivanov J, Žugić V, Škodrić-Trifunović V, Filipović S, Omčikus M. Administering the Sarcoidosis Health Questionnaire to sarcoidosis patients in Serbia. J Bras Pneumol 2017; 42:99-105. [PMID: 27167430 PMCID: PMC4853062 DOI: 10.1590/s1806-37562015000000063] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2015] [Accepted: 08/25/2015] [Indexed: 01/08/2023] Open
Abstract
Objective: The aim of this study was to use a Serbian-language version of the disease-specific, self-report Sarcoidosis Health Questionnaire (SHQ), which was designed and originally validated in the United States, to assess health status in sarcoidosis patients in Serbia, as well as validating the instrument for use in the country. Methods: This was a cross-sectional study of 346 patients with biopsy-confirmed sarcoidosis. To evaluate the health status of the patients, we used the SHQ, which was translated into Serbian for the purposes of this study. We compared SHQ scores by patient gender and age, as well as by disease duration and treatment. Lower SHQ scores indicate poorer health status. Results: The SHQ scores demonstrated differences in health status among subgroups of the sarcoidosis patients evaluated. Health status was found to be significantly poorer among female patients and older patients, as well as among those with chronic sarcoidosis or extrapulmonary manifestations of the disease. Monotherapy with methotrexate was found to be associated with better health status than was monotherapy with prednisone or combination therapy with prednisone and methotrexate. Conclusions: The SHQ is a reliable, disease-specific, self-report instrument. Although originally designed for use in the United States, the SHQ could be a useful tool for the assessment of health status in various non-English-speaking populations of sarcoidosis patients.
Collapse
Affiliation(s)
| | - Branislav Gvozdenović
- Pharmacovigilance Department, Pharmaceutical Product Development Serbia, Belgrade, Serbia
| | | | - Mira Vuković
- Education Department, Health Center Valjevo, Valjevo, Serbia
| | | | | | | | | | | | | | - Maja Omčikus
- School of Medicine, University of Belgrade, Belgrade, Serbia
| |
Collapse
|
6
|
Popević S, Šumarac Z, Jovanović D, Babić D, Stjepanović M, Jovičić S, Šobić-Šaranović D, Filipović S, Gvozdenović B, Omčikus M, Milovanović A, Videnović-Ivanov J, Radović A, Žugić V, Mihailović-Vučinić V. Verifying Sarcoidosis Activity: Chitotriosidase versus ACE in Sarcoidosis - a Case-control Study. J Med Biochem 2016; 35:390-400. [PMID: 28670191 PMCID: PMC5471634 DOI: 10.1515/jomb-2016-0017] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2016] [Accepted: 04/08/2016] [Indexed: 12/12/2022] Open
Abstract
Background Until now, a proper biomarker(s) to evaluate sarcoidosis activity has not been recognized. The aims of this study were to evaluate the sensitivity and specificity of the two biomarkers of sarcoidosis activity already in use (serum angiotensin converting enzyme – ACE and serum chitotriosidase) in a population of 430 sarcoidosis patients. The activities of these markers were also analyzed in a group of 264 healthy controls. Methods Four hundred and thirty biopsy positive sarcoidosis patients were divided into groups with active and inactive disease, and groups with acute or chronic disease. In a subgroup of 55 sarcoidosis patients, activity was also assessed by F-18 fluorodeoxyglucose positron emission tomography (18F-FDG-PET) scanning. Both serum chitotriosidase and ACE levels showed non-normal distribution, so nonparametric tests were used in statistical analysis. Results Serum chitotriosidase activities were almost 6 times higher in patients with active sarcoidosis than in healthy controls and inactive disease. A serum chitotriosidase value of 100 nmol/mL/h had the sensitivity of .5% and specificity of 70.0%. A serum ACE activity cutoff value of 32.0 U/L had the sensitivity of 66.0% and the specificity of 54%. A statistically significant correlation was obtained between the focal granulomatous activity detected on 18F-FDG PET/CT and serum chitotriosidase levels, but no such correlation was found with ACE. The levels of serum chitotriosidase activity significantly correlated with the disease duration (P < 0.0001). Also, serum chitotriosidase significantly correlated with clinical outcome status (COS) categories (ρ =0.272, P =0.001). Conclusions Serum chitotriosidase proved to be a reliable biomarker of sarcoidosis activity and disease chronicity.
Collapse
Affiliation(s)
- Spasoje Popević
- Medical Faculty, University of Belgrade, Serbia.,Clinic of Pulmonary Diseases, Clinical Center of Serbia, Belgrade, Serbia
| | - Zorica Šumarac
- Center for Medical Biochemistry, Clinical Center of Serbia, Belgrade, Serbia
| | - Dragana Jovanović
- Medical Faculty, University of Belgrade, Serbia.,Clinic of Pulmonary Diseases, Clinical Center of Serbia, Belgrade, Serbia
| | - Dragan Babić
- Institute of Medical Statistics and Informatics, Medical Faculty, University of Belgrade, Serbia
| | | | - Snežana Jovičić
- Center for Medical Biochemistry, Clinical Center of Serbia, Belgrade, Serbia.,Department of Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, Serbia
| | - Dragana Šobić-Šaranović
- Medical Faculty, University of Belgrade, Serbia.,Clinic of Pulmonary Diseases, Clinical Center of Serbia, Belgrade, Serbia
| | - Snežana Filipović
- Clinic of Pulmonary Diseases, Clinical Center of Serbia, Belgrade, Serbia
| | | | - Maja Omčikus
- Clinic of Pulmonary Diseases, Clinical Center of Serbia, Belgrade, Serbia
| | - Anđela Milovanović
- Clinic for Physical Medicine and Rehabilitation, Clinical Center of Serbia, Belgrade, Serbia
| | | | - Ana Radović
- Center for Medical Biochemistry, Clinical Center of Serbia, Belgrade, Serbia
| | - Vladimir Žugić
- Medical Faculty, University of Belgrade, Serbia.,Clinic of Pulmonary Diseases, Clinical Center of Serbia, Belgrade, Serbia
| | - Violeta Mihailović-Vučinić
- Medical Faculty, University of Belgrade, Serbia.,Clinic of Pulmonary Diseases, Clinical Center of Serbia, Belgrade, Serbia
| |
Collapse
|
7
|
Stojković-Lalošević M, Stjepanović M, Čolović N, Marić-Živković J, Mihailović-Vučinić V, Stojković M. Postponed diagnosis of alpha-1 antitrypsin deficiency. SRP ARK CELOK LEK 2016; 144:676-677. [PMID: 29659238] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/08/2023] Open
|